Related references
Note: Only part of the references are listed.Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
Katja Klausz et al.
HAEMATOLOGICA (2021)
Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
Hyun Tae Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Targeting a neoantigen derived from a common TP53 mutation
Emily Han-Chung Hsiue et al.
SCIENCE (2021)
Bispecific antibodies targeting mutant RAS neoantigens
Jacqueline Douglass et al.
SCIENCE IMMUNOLOGY (2021)
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
Niklas Baumann et al.
CANCER SCIENCE (2021)
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
Johannes Duell et al.
HAEMATOLOGICA (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Sagar Lonial et al.
LANCET ONCOLOGY (2020)
Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma
Francesca Bonello et al.
CANCERS (2020)
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
Gilles Salles et al.
LANCET ONCOLOGY (2020)
Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs
Kris Barreto et al.
NUCLEIC ACIDS RESEARCH (2019)
Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes
Anne Ljungars et al.
FRONTIERS IN PHARMACOLOGY (2019)
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab
Thomas G. Martin et al.
CELLS (2019)
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Thomas D. Goddard et al.
PROTEIN SCIENCE (2018)
Characterization of the naive murine antibody repertoire using unamplified high-throughput sequencing
Trisha A. Rettig et al.
PLOS ONE (2018)
ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data
Vojtech Bystry et al.
BIOINFORMATICS (2017)
Trends in overall survival and costs of multiple myeloma, 2000-2014
R. Fonseca et al.
LEUKEMIA (2017)
Mining Naive Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
Haiyong Peng et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
Katja Klausz et al.
ONCOTARGET (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Next-generation sequencing enables the discovery of more diverse positive clones from a phage-displayed antibody library
Wonjun Yang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide
H. Jiang et al.
LEUKEMIA (2016)
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma
Inger S. Nijhof et al.
BLOOD (2016)
Monoclonal Antibodies for the Treatment of Myeloma Targeting SLAMF7 and CD38
Sagar Lonial
CANCER JOURNAL (2016)
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
Niels W. C. J. van de Donk et al.
IMMUNOLOGICAL REVIEWS (2016)
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2016)
Phage display-derived human antibodies in clinical development and therapy
Andre Frenzel et al.
MABS (2016)
Generation and analysis of the improved human HAL9/10 antibody phage display libraries
Jonas Kuegler et al.
BMC BIOTECHNOLOGY (2015)
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Markus Hansson et al.
CLINICAL CANCER RESEARCH (2015)
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Marije B. Overdijk et al.
MABS (2015)
NAD+-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model
Alberto L. Horenstein et al.
CELLS (2015)
SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
Jutta Deckert et al.
CLINICAL CANCER RESEARCH (2014)
A Human ICAM-1 Antibody Isolated by a Function-First Approach Has Potent Macrophage-Dependent Antimyeloma Activity In Vivo
Niina Veitonmaki et al.
CANCER CELL (2013)
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma
Y. Zheng et al.
LEUKEMIA (2013)
Deep sequencing of phage display libraries to support antibody discovery
Ulla Ravn et al.
METHODS (2013)
Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining
Ido Saggy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Immunoglobulin AnalysisTool: a novel tool for the analysis of human and mouse heavy and light chain transcripts
Tobias Rogosch et al.
FRONTIERS IN IMMUNOLOGY (2012)
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
Michel de Weers et al.
JOURNAL OF IMMUNOLOGY (2011)
HuCAL PLATINUM, a Synthetic Fab Library Optimized for Sequence Diversity and Superior Performance in Mammalian Expression Systems
Josef Prassler et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2010)
By-passing in vitro screening-next generation sequencing technologies applied to antibody display and in silico candidate selection
U. Ravn et al.
NUCLEIC ACIDS RESEARCH (2010)
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Matthias Peipp et al.
BLOOD (2008)
Selection of an affinity-matured antibody against a defined epitope by phage display of an immune antibody library
Sang Jick Kim et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells
M Schwemmlein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
C-type lectin-like molecule-1: A novel myeloid cell surface marker associated with acute myeloid leukemia
ABH Bakker et al.
CANCER RESEARCH (2004)
An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells
M Peipp et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries
E Söderlind et al.
NATURE BIOTECHNOLOGY (2000)
Share Paper
